Correlation Between Apple and SCHOTT Pharma
Specify exactly 2 symbols:
By analyzing existing cross correlation between Apple Inc and SCHOTT Pharma AG, you can compare the effects of market volatilities on Apple and SCHOTT Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apple with a short position of SCHOTT Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apple and SCHOTT Pharma.
Diversification Opportunities for Apple and SCHOTT Pharma
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Apple and SCHOTT is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Apple Inc and SCHOTT Pharma AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SCHOTT Pharma AG and Apple is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apple Inc are associated (or correlated) with SCHOTT Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SCHOTT Pharma AG has no effect on the direction of Apple i.e., Apple and SCHOTT Pharma go up and down completely randomly.
Pair Corralation between Apple and SCHOTT Pharma
Assuming the 90 days trading horizon Apple Inc is expected to generate 0.69 times more return on investment than SCHOTT Pharma. However, Apple Inc is 1.44 times less risky than SCHOTT Pharma. It trades about 0.13 of its potential returns per unit of risk. SCHOTT Pharma AG is currently generating about -0.15 per unit of risk. If you would invest 20,750 in Apple Inc on August 30, 2024 and sell it today you would earn a total of 1,475 from holding Apple Inc or generate 7.11% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 97.73% |
| Values | Daily Returns |
Apple Inc vs. SCHOTT Pharma AG
Performance |
| Timeline |
| Apple Inc |
| SCHOTT Pharma AG |
Apple and SCHOTT Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apple and SCHOTT Pharma
The main advantage of trading using opposite Apple and SCHOTT Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apple position performs unexpectedly, SCHOTT Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SCHOTT Pharma will offset losses from the drop in SCHOTT Pharma's long position.| Apple vs. PLAYSTUDIOS A DL 0001 | Apple vs. COLUMBIA SPORTSWEAR | Apple vs. LG Display Co | Apple vs. Aedas Homes SA |
| SCHOTT Pharma vs. Apple Inc | SCHOTT Pharma vs. Apple Inc | SCHOTT Pharma vs. Apple Inc | SCHOTT Pharma vs. Apple Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |